NEUROCRINE BIOSCIENCES INC
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- biotechnology [1]
- Company / filing name
- NEUROCRINE BIOSCIENCES INC [2]
- Headquarters location
- San Diego [1]
- Founded
- 1992 [1]
- Legal form
- Delaware corporation [1]
- Official website
- www.neurocrine.com ↗ [1]
- ISIN (reported securities)
- US64125C1099 [1]
- CIK
- 914475 [2]
- Country in background record
- United States [1]
- Symbols / exchanges
- NBIX (Nasdaq) [2]
Company positioning and business
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD). [3]
The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. [3]
Background text: Wikipedia contributors, Neurocrine Biosciences. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: NBIX (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was NEUROCRINE BIOSCIENCES INC founded?
Founded: 1992. The linked source provides the background record. [1]
Where is the headquarters of NEUROCRINE BIOSCIENCES INC?
Headquarters location: San Diego. The linked source provides the background record. [1]
Which business sectors are recorded for NEUROCRINE BIOSCIENCES INC?
Business sectors: biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Neurocrine Biosciences (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.